Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
Science Translational Medicine|December 17, 2025
An orally bioavailable MrgprX1-positive allosteric modulator alleviates certain neuropathic pain-related behaviors in humanized miceAnkit Uniyal, Niyada Hin, Chi Zhang, et al.
Pain|July 18, 2018
Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacyNanna B Finnerup, Simon Haroutounian, Ralf Baron, et al.
Neurology|October 22, 2020
Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated AmyloidosisSimina Ticau, Gautham V Sridharan, Shira Tsour, et al.
Orphanet Journal of Rare Diseases|July 10, 2020
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosisTeresa Coelho, David Adams, Isabel Conceição, et al.
Muscle & Nerve|July 13, 2020
mNIS+7 and lower limb function in inotersen treatment of hereditary transthyretin-mediated amyloidosisP James B Dyck, John C Kincaid, Janice F Wiesman, et al.
The Lancet. Neurology|January 11, 2015
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisNanna B Finnerup, Nadine Attal, Simon Haroutounian, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 18, 2024
Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trialJonas Wixner, John L Berk, David Adams, et al.
Neurology|May 5, 2021
Large Mitochondrial DNA Deletions in HIV Sensory NeuropathyRicardo H Roda, David Bargiela, Weiran Chen, et al.
Pageof 22